Peucedanum japonicum extract attenuates allergic airway inflammation by inhibiting Th2 cell activation and production of pro-inflammatory mediators. (30th January 2018)

• Record Type: Journal Article
• Authors: Chun, Jin Mi; Lee, A. Reum; Kim, Hyo Seon; Lee, A. Yeong; Gu, Gyo Jeong; Moon, Byeong Cheol; Kwon, Bo-In
• Is Part Of: Journal of ethnopharmacology. Volume 211(2017)
• Page Start: 78
• Page End: 88
• Publication Date: 2018-01-30
• Subjects: BALF bronchoalveolar lavage fluid -- COX-2 cyclooxygenase-2 -- GATA-3 GATA-binding protein-3 -- LC/MS liquid chromatography mass spectrometry -- IgE immunoglobulin E -- IL interleukin -- iNOS inducible nitric oxide synthase -- LPS lipopolysaccharide -- NO nitric oxide -- OVA ovalbumin -- PJ Peucedanum japonicum -- PJE Peucedanum japonicum extract -- PGE2 prostaglandin E2 -- Th2 T helper 2 -- TNF-α tumor necrosis factor-α; Peucedanum japonicum -- Allergic lung inflammation -- Type2 cytokines -- T helper 2 cell activation -- RAW264.7 cells -- Pro-inflammatory mediators; Ethnopharmacology -- Periodicals; Pharmacognosy -- Periodicals; Herbs -- Periodicals; Herbs -- Periodicals; Pharmacognosy -- Periodicals; Pharmacognosie -- Périodiques; Herbes -- Périodiques; 615.1
• DOI: 10.1016/j.jep.2017.09.006
• Languages: English
• ISSNs: 0378-8741

Abstract

Abstract: Ethnopharmacological relevance: The root of Peucedanum japonicum Thunberg is traditionally used to treat coughs, colds, headache and inflammatory diseases in Korea and Japan. Its effects on allergic lung inflammation have not been investigated. Aim of the study: To investigate the anti-asthmatic effects of Peucedanum japonicum extract (PJE) using a murine model of asthma and a lipopolysaccharide (LPS)-stimulated macrophage cell line. Materials and methods: Mice underwent two rounds of sensitization with ovalbumin 1 week apart followed by four intranasal ovalbumin challenges on days 13–16. The control group received saline only. Two ovalbumin-sensitized groups were orally administered vehicle or PJE (200 mg/kg) 5 days a week starting 1 week before the first ovalbumin sensitization. The third group was orally administered the asthma medication Montelukast (10 mg/kg) on days 12–16. All animals were sacrificed on day 17. The lungs were assessed for histological features, inflammatory cell infiltration, Th2 cell activation and GATA-binding protein-3 (GATA-3) expression. The bronchoalveolar lavage fluid (BALF) was assessed for type 2 cytokine levels. The effect of PJE on the in vitro Th2 polarization of naïve CD4 + splenocytes and the production of pro-inflammatory mediators and cytokines by LPS-stimulated RAW 264.7 cells was evaluated. Results: PJE treatment inhibited OVA-induced inflammatory cell infiltration, eosinophilia, Th2 activation, and GATA-3 expression in the lung, reduced the interleukin (IL)-5 and IL-13 levels in BALF, down-regulated Th2 activation in vitro, and inhibited the macrophage production of inducible nitric oxide, cyclooxygenase-2, tumor necrosis factor-α, and IL-6. Conclusion: PJE attenuated allergic airway inflammation by inhibiting Th2 cell activation and macrophage production of inflammatory mediators. Peucedanum japonicum may be candidate therapy for allergic lung inflammation. Graphical abstract: